Your SlideShare is downloading. ×
  • Like
Global Healthcare Cold Chain Logistics Market Report & Forecast (2011-2016)
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Now you can save presentations on your phone or tablet

Available for both IPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Global Healthcare Cold Chain Logistics Market Report & Forecast (2011-2016)

  • 461 views
Published

Driven by a strong growth in the sales of temperature sensitive healthcare products, the demand for cold chain logistic services is currently experiencing explosive growth. IMARC Group, one of the …

Driven by a strong growth in the sales of temperature sensitive healthcare products, the demand for cold chain logistic services is currently experiencing explosive growth. IMARC Group, one of the world’s leading research and advisory firms, finds that the total size of the healthcare cold chain logistic services market is expected to expand from its current figures of US$ 6.1 billion to nearly US$ 9.5 billion by 2016.

Published in Business , Health & Medicine
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
No Downloads

Views

Total Views
461
On SlideShare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
19
Comments
0
Likes
1

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Report Description & HighlightsDriven by a strong growth in the sales of temperature sensitive healthcare products, thedemand for cold chain logistic services is currently experiencing explosive growth. IMARCGroup, one of the world’s leading research and advisory firms, finds that the total size of thehealthcare cold chain logistic services market is expected to expand from its current figuresof US$ 6.1 billion to nearly US$ 9.5 billion by 2016.IMARC’s new report entitled “Global Healthcare Cold Chain Logistics Market Report &Forecast (2011-2016)” provides an analytical and statistical insight into the logisticopportunities in the global healthcare market. The study that has been undertaken using bothdesk based as well as qualitative primary market research has analyzed three aspects of theglobal healthcare cold chain logistics market.The first aspect involves the quantification of the global market for temperature sensitivehealthcare products into three major classes and evaluation of the current and futureopportunities in each of these classes. The second aspect involves an in-depth understandingon the global healthcare cold chain distribution process and logistic requirements for varioustemperature sensitive healthcare products. The third aspect involves the quantification of theglobal healthcare cold chain logistic services market and a comprehensive evaluation of itsvarious segments.What we have achieved in this report:Comprehensive Market Analysis of Temperature Sensitive Healthcare Products:Classes Covered: Biopharmaceuticals, Vaccines & Clinical Trial MaterialsFocus of the Analysis in Each Class: Drivers and challenges Historical sales trends Logistic requirements Impact of temperature excursions Opportunities in cold chain services Market outlook (2011-2016)imarc© 3
  • 2. Understanding the Operations of a Healthcare Cold Chain Distribution ProcessFocus of the Analysis: Understanding the various methods of cold chain distribution and their advantages/disadvantages Understanding the cold chain requirements for various temperature sensitive healthcare products and the impact of temperature excursions Understanding the various costs involved in cold chain transportation and comparing it with non-cold chain transportation Understanding the key steps required in the setting and organization of an efficient cold chain distribution processComprehensive Market Analysis of the Healthcare Cold Chain Logistic Services MarketFocus of the analysis: Quantifying the global healthcare cold chain logistic services market Quantifying the market size by product Quantifying the market size by service Quantifying the market size by regionInformation Sources:Information has been sourced from both primary and secondary sources: Primary sources include industry surveys and face to face/telephone interviews with industry experts. Secondary sources include proprietary databases and search engines. These sources include company websites and reports, books, trade journals, magazines, white papers, industry portals, government sources and access to more than 4000 paid databases.imarc© 4
  • 3. Table of Contents1 Research Methodology & Market Definitions ................................................................................................. 102 Executive Summary .......................................................................................................................................... 123 The Global Healthcare Cold Chain Logistics Market ..................................................................................... 14 3.1 Current Trends .......................................................................................................................................... 14 3.1.1 Healthcare Cold Chain Products are Exhibiting Exponential Growth ................................................. 14 3.1.2 Temperature Sensitive Healthcare Products Have Well Defined Logistic Needs............................... 15 3.1.3 Outsourcing Trends in Research & Manufacturing Have Increased Logistic Demands ..................... 17 3.1.4 Increasing Regulatory Focus on the Integrity of Transported Healthcare Products ........................... 19 3.1.5 Cost is Not Always the Most Important Driver in Supplier Decisions ................................................. 214 The Global Healthcare Cold Chain Products Market ..................................................................................... 22 4.1 Current Market Trends & Forecast .......................................................................................................... 22 4.2 Market Segments ...................................................................................................................................... 25 4.2.1 Biopharmaceuticals............................................................................................................................ 25 4.2.1.1 Current Market Trends & Forecast ................................................................................................ 25 4.2.1.2 Cold Chain Requirements for Biopharmaceuticals ........................................................................ 28 4.2.1.3 Cold Chain Opportunities for Biopharmaceuticals ......................................................................... 30 4.2.2 Vaccines ............................................................................................................................................ 36 4.2.2.1 Current Market Trends & Forecast ................................................................................................ 36 4.2.2.2 Cold Chain Requirements for Vaccines ......................................................................................... 38 4.2.2.3 Cold Chain Opportunities for Vaccines .......................................................................................... 40 4.2.3 Clinical Trial Materials ........................................................................................................................ 43 4.2.3.1 Current Market Trends & Forecast ................................................................................................ 43 4.2.3.2 Cold Chain Requirements for Clinical Trial Materials .................................................................... 46 4.2.3.3 Cold Chain Opportunities for Clinical Trial Materials ..................................................................... 475 Healthcare Cold Chain Logistics: How Does It Operate? .............................................................................. 51 5.1 Cold Chain Packaging & Transportation Methods ................................................................................ 51 5.1.1 Dry Ice ............................................................................................................................................... 52 5.1.2 Liquid Nitrogen ................................................................................................................................... 53 5.1.3 Gel Packs .......................................................................................................................................... 54 5.2 Modeling the Cost of Cold Chain Packaging & Transportation ............................................................ 56 5.3 Setting Up a Cold Chain ........................................................................................................................... 57 5.3.1 Initial Considerations .......................................................................................................................... 57 5.3.2 Choosing the Correct Model .............................................................................................................. 58 5.3.3 Regulatory/Custom Clearance ........................................................................................................... 59 5.3.4 Final Stages ....................................................................................................................................... 59 5.3.5 Quality Assurance .............................................................................................................................. 606 The Healthcare Cold Chain Logistic Services Market .................................................................................... 61 6.1 Current Trends & Forecast ...................................................................................................................... 61imarc© 5
  • 4. 6.2 Market Segmentation ............................................................................................................................... 63 6.2.1 Market by Product .............................................................................................................................. 63 6.2.1.1 Biopharmaceuticals & Vaccines .................................................................................................... 63 6.2.1.2 Clinical Trial Materials ................................................................................................................... 64 6.2.2 Market by Segment ............................................................................................................................ 66 6.2.2.1 Packaging & Instrumentation ......................................................................................................... 66 6.2.2.2 Transportation ............................................................................................................................... 68 6.2.3 Market by Region ............................................................................................................................... 71 6.2.3.1 North America................................................................................................................................ 71 6.2.3.2 Europe ........................................................................................................................................... 72 6.2.3.3 Asia Pacific .................................................................................................................................... 73 6.2.3.4 Rest of the World ........................................................................................................................... 757 Challenges in the Healthcare Cold Chain Logistics Market .......................................................................... 77 7.1 Cold Chain Infrastructure Remains Underdeveloped in Many Regions .............................................. 77 7.2 Lack of Funding to Implement an Efficient Cold Chain Infrastructure ................................................ 77 7.3 New Technologies Nullifying the Need of Cold Chains......................................................................... 788 Key Company Profiles ...................................................................................................................................... 80 8.1 World Courier............................................................................................................................................ 80 8.2 DHL ............................................................................................................................................................ 80 8.3 Fedex ......................................................................................................................................................... 81 8.4 United Parcel Service ............................................................................................................................... 82 8.5 Kuehne and Nagel .................................................................................................................................... 82 8.6 Cavalier Logistics ..................................................................................................................................... 83 8.7 DB Schenker ............................................................................................................................................. 84 8.8 Life ConEx ................................................................................................................................................. 84 8.9 American Airlines Cargo .......................................................................................................................... 85 8.10 Continental Air Cargo............................................................................................................................... 86 8.11 Marken ....................................................................................................................................................... 86imarc© 6
  • 5. List of FiguresFigure 3-1: Global - Healthcare Cold & Non Cold Chain Products Markets (in Billion US$), 2009-2010...................... 14Figure 3-2: Global - Healthcare Cold & Non Cold Chain Products Market Forecast (in Billion US$), 2011-2016 ........ 15Figure 3-3: Global - Potency of the Tetanus Component of a DTP Vaccine Stored for 45 Days at VariousTemperatures ............................................................................................................................................................... 16Figure 3-4: Global - Contract Research & Manufacturing Market (in Billion US$), 2007-2010 ..................................... 18Figure 3-5: Global - Contract Research & Manufacturing Market Forecasts (in Billion US$), 2011-2016 .................... 18Figure 3-6: Estimated Costs incurred in Various Pharmaceutical Operations .............................................................. 21Figure 4-1: Global - Healthcare Cold Chain Products Market - Break up by Product (in %), 2009-2010 ..................... 24Figure 4-2: Global - Healthcare Cold Chain Products Market Forecast - Break up by Product (in %), 2011-2016 ...... 24Figure 4-3: Global - Biopharmaceutical Market (in Billion US$), 2008-2010 ................................................................ 26Figure 4-4: Global - Biopharmaceutical Market Forecast (in Billion US$), 2011-2016 ................................................. 27Figure 4-5: US & Europe - Biosimilar Sales & Forecast (in Million US$), 2007-2016 ................................................... 32Figure 4-6: Global - Share of Biopharmaceutical Manufacturers Planning to Outsource Some Production to ContractManufacturers, (in %), 2006 & 2011............................................................................................................................. 33Figure 4-7: Global - Biopharmaceutical Contract Manufacturing Market (in Billion US$), 2009-2010 .......................... 33Figure 4-8: Global - Biopharmaceutical Contract Manufacturing Market Forecast (in Billion US$), 2011-2016 ........... 34Figure 4-9: Global - Vaccine Market (in Billion US$), 2008-2010 ................................................................................. 37Figure 4-10: Global - Vaccine Market Forecast (in Billion US$), 2011-2016 ................................................................ 37Figure 4-11: Global - Vaccine Production Volume by Region (in %), 2008 .................................................................. 41Figure 4-12: Europe - Vaccine Export Volume by Region (in %), 2008 ........................................................................ 42Figure 4-13: Global - Clinical Trials Market (in Billion US$), 2009-2010 ...................................................................... 43Figure 4-14: Time Taken for Biopharmaceuticals to Get Approved (in Months), 1982-2009........................................ 45Figure 4-15: Global - Clinical Trials Market Forecast (in Billion US$), 2011-2016 ....................................................... 45Figure 4-16: Number of Multinational Clinical Trials (Phase II and III) in Asian Countries by the Top Twenty GlobalPharmaceutical Companies* ........................................................................................................................................ 48Figure 4-17: Global - Break up of Biopharmaceuticals & Small Molecule Drugs in Preclinical & Clinical trials, (in %),2009 ............................................................................................................................................................................. 49Figure 4-18: Top Reasons for Conducting Clinical Trials in Each Country (in %), 2009 .............................................. 50Figure 5-1: A Typical Drug Supply Chain from the Manufacturer to the End User ....................................................... 51Figure 6-1: Global - Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008-2010 .............................. 61Figure 6-2: Global - Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2011-2016 ............... 62Figure 6-3: Global - Healthcare Logistic Services Market, Share of Cold-Chain & Non Cold-Chain Services, (in %),2008 ............................................................................................................................................................................. 62Figure 6-4: Global - Healthcare Cold Chain Logistic Services Market by Product (in %), 2010 & 2016 ....................... 63Figure 6-5: Global - Biopharmaceuticals & Vaccines Cold Chain Logistic Services Market (in Billion US$), 2008-2010..................................................................................................................................................................................... 64Figure 6-6: Global - Biopharmaceuticals & Vaccines Cold Chain Logistic Services Market Forecast (in Billion US$),2011-2016 .................................................................................................................................................................... 64Figure 6-7: Global - Clinical Trial Materials Cold Chain Logistic Services Market (in Billion US$), 2008-2010 ............ 65Figure 6-8: Global - Clinical Trial Materials Cold Chain Logistic Services Market Forecast (in Billion US$), 2011-2016..................................................................................................................................................................................... 66imarc© 7
  • 6. Figure 6-9: Global - Healthcare Cold Chain Logistic Services Market by Segment (in %), 2010 & 2016 ..................... 66Figure 6-10: Global - Healthcare Cold Chain Packaging & Instrumentation Services Market (in Billion US$), 2008-2010 ............................................................................................................................................................................. 67Figure 6-11: Global - Healthcare Cold Chain Packaging & Instrumentation Services Market Forecast (in Billion US$),2011-2016 .................................................................................................................................................................... 68Figure 6-12: Global - Healthcare Packaging & Instrumentation Services Market, Share of Cold-Chain & Non Cold-Chain Services, (in %), 2008 ........................................................................................................................................ 68Figure 6-13: Global - Healthcare Cold Chain Transportation Services Market (in Billion US$), 2008-2010 ................. 69Figure 6-14: Global - Healthcare Cold Chain Transportation Services Market Forecast (in Billion US$), 2011-2016 .. 70Figure 6-15: Global - Healthcare Transportation Services Market, Share of Cold-Chain & Non Cold-Chain Services,(in %), 2008 .................................................................................................................................................................. 70Figure 6-16: Global - Healthcare Cold Chain Logistic Services Market by Region (in %), 2010 & 2016 ...................... 71Figure 6-17: North America - Healthcare Cold Chain Logistic Services Market - (in Billion US$), 2008-2010 ............. 72Figure 6-18: North America - Healthcare Cold Chain Logistic Services Market Forecast - (in Billion US$), 2011-2016..................................................................................................................................................................................... 72Figure 6-19: Europe - Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008-2010 ........................... 73Figure 6-20: Europe - Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2011-2016 ............ 73Figure 6-21: Asia Pacific - Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008-2010 .................... 74Figure 6-22: Asia Pacific - Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2011-2016 ..... 75Figure 6-23: Rest of the World - Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008 - 2010......... 75Figure 6-24: Rest of the World - Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2011-2016..................................................................................................................................................................................... 76Figure 7-1: Financing Sources and Gaps (in %), 2008-2010 ....................................................................................... 78imarc© 8
  • 7. List of TablesTable 3-1: Various Regulations on Healthcare Cold Chain Logistic Requirements ...................................................... 20Table 4-1: Global - Healthcare Cold Chain Products Market - Break up by Product (in Billion US$), 2009-2010 ........ 23Table 4-2: Global - Healthcare Cold Chain Products Market Forecast - Break up by Product (in Billion US$), 2011-2016 ............................................................................................................................................................................. 24Table 4-3: Global - Biopharmaceutical Market - Sales by Class (in Billion US$), 2008-2010....................................... 27Table 4-4: Global - Biopharmaceutical Market Forecast - Sales by Class (in Billion US$), 2011-2016 ........................ 28Table 4-5: Stability of Various Biopharmaceuticals at Room Temperature .................................................................. 30Table 4-6: US & Europe - Launch Dates of Various Biosimilars................................................................................... 31Table 4-7: US & Europe - Biosimilar Market Sales & Forecast (in Million US$), 2007-2016 ........................................ 32Table 4-8: Complexity of the Manufacturing Process Involved with Biopharmaceuticals & Small Molecule Drugs ...... 35Table 4-9: Temperature Stability of Commonly Used Vaccines ................................................................................... 39Table 4-10: The Effect of Temperature Excursions on the Usability of Vaccines ......................................................... 40Table 4-11: Global - Major Vaccine Production Sites (in Numbers), 2008 ................................................................... 41Table 4-12: Global - Clinical Trials Market - Spending on Biopharmaceuticals & Small Molecule drugs (in Billion US$),2009-2010 .................................................................................................................................................................... 43Table 4-13: Global - Patent Expiry Risks of Big Pharmaceutical Companies, 2011-2013............................................ 44Table 4-14: Global - Clinical Trials Market Forecast – Spending on Biopharmaceuticals & Small Molecule Drugs (inBillion US$), 2011-2016 ............................................................................................................................................... 45Table 4-15: Ideal Storage Temperatures for Clinical Trial Materials ............................................................................ 47Table 5-1: Average Amount of Dry Ice for Packaging Frozen Goods in a Single Well Insulated Container ................. 52Table 5-2: Dry Ice Containers ...................................................................................................................................... 53Table 5-3: Refrigerated Shipping Containers with Gel Packs ...................................................................................... 56Table 5-4 : Costs Associated With the Cold Chain Shipment of Healthcare Products, 2011* ...................................... 57Table 5-5 : Costs Associated With the Non-Cold Chain Shipment of Healthcare Products, 2011* .............................. 57Table 7-1: Cold Chain & Logistic Funding Gaps Per Infant (in US$), 2008-2010 ......................................................... 78imarc© 9
  • 8. Prices and Order Information Single user license Single user license Single user license Multiple user license PDF CD ROM Hard Copy All Formats US$ 1200 US$ 1400 US$ 1400 US$ 1900I would like to order the market study “Global Healthcare Cold Chain LogisticsMarket Report & Forecast (2011-2016)”. Kindly Complete Your DetailsYour Name:Job Title:Company:Email Id:Telephone Number:Adress: Contact IMARC GroupKrishna SharmaInternational Market Research Analysis and Consulting Group : +91-11-4256531 (Asia), +1-631-791-1145 (North America) : sales@imarcgroup.com
  • 9. About IMARCFor more than 5 years, the International Market Analysis Research and Consulting Group hasbeen a leading advisor on management strategy and market research worldwide. We partnerwith clients in all sectors and regions to identify their highest-value opportunities, address theirmost critical challenges, and transform their businesses.IMARCs information products include major market, scientific, economic and technologicaldevelopments for business leaders in pharmaceutical, industrial, and high technologyorganizations. Market forecasts and industry analysis for biotechnology, advanced materials,pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processingmethods are at the top of the companys expertise.IMARC’s tailored approach combines unfathomable insight into the dynamics of companies andmarkets with close cooperation at all levels of the client organization. This ensures that ourclients achieve unmatchable competitive advantage, build more proficient organizations, andsecure lasting results.imarc©